Articles
2,5-DIMERKAPTO-1,3,4-TIADIAZOLNI GIDRAZINLI KOMPLEKSINI BIOLOGIK FAOLLIGINI IN SILICO USULLAR YORDAMIDA BAHOLASH
Published 04-05-2026
Keywords
- 1,3,4-tiadiazol, molekulyar dokking, PASS Online, PTP1B, in silico, biologik faollik.

This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
2,5-DIMERKAPTO-1,3,4-TIADIAZOLNI GIDRAZINLI KOMPLEKSINI BIOLOGIK FAOLLIGINI IN SILICO USULLAR YORDAMIDA BAHOLASH. (2026). INTERNATIONAL JOURNAL OF SCIENCE AND TECHNOLOGY, 3(04), 84-85. https://doi.org/10.70728/conf.edu.v3.i4.018
Abstract
Ushbu ishda 2,2’-((1,3,4-tiadiazol-2,5- diyil)bis(sulfandiyil)) di(atsetogidrazid) birikmasining biologik faolligi kompyuter modellashtirish usullari yordamida o‘rganildi. PASS Online natijalari moddaning serebral antiishemik va sitoprotektor xususiyatlarini ko‘rsatdi. Molekulyar dokking tahlillari PTP1B oqsili bilan yuqori bog‘lanish energiyasini (-7.7 kkal/mol) aniqladi, bu esa birikmaning diabetga qarshi potentsialini tasdiqlaydi.
References
- 1. Filimonov D.A. et al. (2014). PASS Online: predicting biological activity spectra for chemical compounds. Bioinformatics.
- 2. Trott O., Olson A.J. (2010). AutoDock Vina: improving the speed and accuracy of docking. Journal of Computational Chemistry.
- 3. Jaloliddinov F.Y. va boshqalar. (2025). Tiadiazol hosilalarining sintezi va tahlili. O‘zMU xabarlari.